| P50 | author | Claudia Sommer | Q64762189 |
| | Mads Werner | Q73267560 |
| | Nurcan Üçeyler | Q109819813 |
| P2093 | author name string | Marian Petersen | |
| | Joakim M Bischoff | |
| | Thomas K Ringsted | |
| P2860 | cites work | A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia | Q50440477 |
| | The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. | Q52858127 |
| | Risk factors for long-term pain after hernia surgery | Q79955487 |
| | Pain and sensory dysfunction 6 to 12 months after inguinal herniotomy | Q80390710 |
| | Heterogeneous sensory processing in persistent postherniotomy pain | Q84077399 |
| | Topical capsaicin (high concentration) for chronic neuropathic pain in adults | Q24200709 |
| | CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials | Q24614627 |
| | The hospital anxiety and depression scale | Q27860968 |
| | The time course of CO2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers | Q33546873 |
| | Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia | Q33715079 |
| | Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy | Q34785640 |
| | Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch | Q35203278 |
| | Persistent postsurgical pain: risk factors and prevention | Q36477806 |
| | A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia | Q37775266 |
| | Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain | Q38085034 |
| | Long-term follow-up after mesh removal and selective neurectomy for persistent inguinal postherniorrhaphy pain | Q39230704 |
| | NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study | Q39312497 |
| | The effect of wound instillation of a novel purified capsaicin formulation on postherniotomy pain: a double-blind, randomized, placebo-controlled study | Q42662506 |
| | A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers | Q43094995 |
| | Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients | Q43657114 |
| | Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study | Q44151324 |
| | Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch | Q45056095 |
| | Lidocaine patch (5%) in treatment of persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trial. | Q45143398 |
| | Comparison of cooling and EMLA to reduce the burning pain during capsaicin 8% patch application: a randomized, double-blind, placebo-controlled study | Q45756820 |
| | Operative management of refractory neuropathic inguinodynia by a laparoscopic retroperitoneal approach. | Q46039660 |
| | Demographic and socioeconomic aspects of hernia repair in the United States in 2003 | Q47578051 |
| | Ultrasound-guided ilioinguinal/iliohypogastric nerve blocks for persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trial. | Q48173310 |
| | Long-term pain after inguinal hernia repair in a population-based cohort; risk factors and interference with daily activities | Q48586064 |
| | Functional and structural nerve fiber findings in heterozygote patients with Fabry disease | Q49092843 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | e109144 | |
| P577 | publication date | 2014-10-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A capsaicin (8%) patch in the treatment of severe persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled trial | |
| P478 | volume | 9 | |